Diabetes drug dapagliflozin may benefit patients with heart failure
Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved symptoms and physical limitations in patients with heart failure with preserved ejection fraction, according to clinical trial results published in Nature ...
Nov 30, 2021
0
55